Mavrilimumab (CSF2RA/CD116) - Research Grade Biosimilar
Product Specifications
Background
Mavrilimumab has been investigated for the treatment of Rheumatoid Arthritis.
Immunogen
Homo sapiens / CSF2RA/CD116 [Homo sapiens]
Clonality
Recombinant Monoclonal
Conjugation
Unconjugated
Type
Primary Antibodies, Biosimilars
Source
CHO cells
Field of Research
Neuroscience
Purification
>95%
Concentration
Batch dependent
Buffer
PBS buffer pH7.5
Modification
None
Shipping Conditions
Blue Ice
Storage Conditions
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 ˚ C for 1-2 weeks. Store at -20 ˚ C for 12 months. Store at -80 ˚ C for long term storage.
Fragment
IgG4-lambda2
NCBI Organism
Homo sapiens
Other Product Names
CAM-3001
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LC419413 20 µg
Laminin gamma 1 (LAMC1) (NM_002293) Human Over-expression Lysate
Sign In for Pricing
View Details 
E-EL-M1402-01 24 Tests
Mouse HDL (High Density Lipoprotein) ELISA Kit
Sign In for Pricing
View Details E-EL-M1402-02 48 Tests
Mouse HDL (High Density Lipoprotein) ELISA Kit
Sign In for Pricing
View Details